Grant: DRA: Canada Impact+ Research Training Awards - Doctoral
University of Toronto
$120,000.00
Dual function DNA hydrogels for infection-resistant implants
FY 2025-26
Summary
"Osteoporosis affects over 2.3 million Canadians and makes bones weak and slow to heal, especially around implants.
Further, implant-associated infections (IAI) remain one of the leading causes for implant failure. Current implant coatings to
circumvent the issue often fail due to cytotoxicity, drug resistance, burst release kinetics, and insufficient immune support.
Recently, we developed DNA gels that release signaling cues locally and make cells produce new bone in healthy
pre-clinical models. This project proposes to functionalize these DNA gels with antimicrobial peptides that physically disrupt
bacterial membranes. Our overall goal is to develop peptide-DNA gels as implant coatings that prevent IAI while allowing
osseointegration in osteoporotic bone. The hypothesis is that peptide-DNA gels will improve osteogenic cell recruitment and
differentiation, reduce bacterial infection, and increase bone formation and implant stability. We will study both female and
male osteoporotic pre-clinical models, given that osteoporosis presents differently in men and women. The project will be
achieved in three aims:
1.Synthesis of peptide-DNA gels as implant coatings.
2.In vitro analysis of cytocompatibility and antibacterial properties of peptide-DNA gels.
3.In vivo analysis of gel-coated implants in osteoporotic pre-clinical models.
Feasibility: K. Carneiro is an expert in DNA biomaterials; A. Kumar has experience with antibacterial peptides. This project
is part of a CIHR grant, led by an interdisciplinary team with expertise across all relevant aspects.
Significance: By synchronizing infection control with tissue regeneration, this approach addresses a critical unmet need in
implants and offers a new strategy to prevent implant failure without relying on systemic antibiotics."
Department
Program
DRA: Canada Impact+ Research Training Awards - Doctoral
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
568278
Name
Kumar Abhishek
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
Dual function DNA hydrogels for infection-resistant implants
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Antimicrobial Peptides; Dna Hydrogels; Implant Associated Infections; Osseointegration; Osteoporosis
Abstract
"Osteoporosis affects over 2.3 million Canadians and makes bones weak and slow to heal, especially around implants.
Further, implant-associated infections (IAI) remain one of the leading causes for implant failure. Current implant coatings to
circumvent the issue often fail due to cytotoxicity, drug resistance, burst release kinetics, and insufficient immune support.
Recently, we developed DNA gels that release signaling cues locally and make cells produce new bone in healthy
pre-clinical models. This project proposes to functionalize these DNA gels with antimicrobial peptides that physically disrupt
bacterial membranes. Our overall goal is to develop peptide-DNA gels as implant coatings that prevent IAI while allowing
osseointegration in osteoporotic bone. The hypothesis is that peptide-DNA gels will improve osteogenic cell recruitment and
differentiation, reduce bacterial infection, and increase bone formation and implant stability. We will study both female and
male osteoporotic pre-clinical models, given that osteoporosis presents differently in men and women. The project will be
achieved in three aims:
1.Synthesis of peptide-DNA gels as implant coatings.
2.In vitro analysis of cytocompatibility and antibacterial properties of peptide-DNA gels.
3.In vivo analysis of gel-coated implants in osteoporotic pre-clinical models.
Feasibility: K. Carneiro is an expert in DNA biomaterials; A. Kumar has experience with antibacterial peptides. This project
is part of a CIHR grant, led by an interdisciplinary team with expertise across all relevant aspects.
Significance: By synchronizing infection control with tissue regeneration, this approach addresses a critical unmet need in
implants and offers a new strategy to prevent implant failure without relying on systemic antibiotics."
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kumar, Abhishek
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~